Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
Public ClinicalTrials.gov record NCT01972568. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a multi-center, double-blind, randomized, Phase 2b trial to evaluate the efficacy of atacicept in subjects with systemic lupus erythematosus (SLE).
Study identification
- NCT ID
- NCT01972568
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 306 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2013 (Actual)
- Primary completion
- Apr 2016 (Actual)
- Completion
- Sep 2016 (Actual)
- Last update posted
- Jan 2, 2018
2013 – 2016
United States locations
- U.S. sites
- 30
- U.S. states
- 17
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pinnacle Research Group LLC | Anniston | Alabama | 36207 | — |
| Achieve Clinical Research, LLC | Birmingham | Alabama | 35216 | — |
| University of Alabama at Birmingham - (UAB) | Birmingham | Alabama | 35294 | — |
| Southern California Permanente Medical Group | Anaheim | California | 92806 | — |
| Wallace Rheumatic Study Center | Los Angeles | California | 90048 | — |
| East Bay Rheumatology Medical Group, Inc. | San Leandro | California | 94578 | — |
| Clinical Research of West Florida - Corporate | Dunedin | Florida | 34698 | — |
| Center for Rheumatology, Immunology & Arthritis | Fort Lauderdale | Florida | 33309 | — |
| University of Miami Miller School of Medicine | Miami | Florida | 33136 | — |
| Clinical Research of West Florida, Inc. | Tampa | Florida | 33603 | — |
| Goldpoint Clinical Research, LLC | Indianapolis | Indiana | 46260 | — |
| AA MRC LLC Ahmed Arif Medical Research Center | Grand Blanc | Michigan | 48439 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
| North MS Medical Clinics, Inc. | Tupelo | Mississippi | 38801 | — |
| Washington University School of Medicine | St Louis | Missouri | 63110 | — |
| Rutgers New Jersey Medical School | Newark | New Jersey | 07103 | — |
| The Feinstein Institute for Medical Research | Manhasset | New York | 11031 | — |
| Hospital for Special Surgery | New York | New York | 10021 | — |
| Box Arthritis & Rheumatology of the Carolinas PLLC | Charlotte | North Carolina | 28210 | — |
| MetroHealth System | Cleveland | Ohio | 44109 | — |
| Ohio State University Medical Center | Columbus | Ohio | 43210 | — |
| STAT Research, Inc. | Dayton | Ohio | 45417 | — |
| Arthritis & Rheumatology Center of Oklahoma | Oklahoma City | Oklahoma | 73103 | — |
| OMRF | Oklahoma City | Oklahoma | 73104 | — |
| Lynn Health Science Institute | Oklahoma City | Oklahoma | 73112 | — |
| Clinical Research Center of Reading LLC | Wyomissing | Pennsylvania | 19610 | — |
| Medical University of South Carolina (MUSC) | Charleston | South Carolina | 29425 | — |
| UTMB Pathology Clinical Services | Galveston | Texas | 77555 | — |
| Arthritis & Osteoporosis Clinic | Waco | Texas | 76708 | — |
| Danville Orthopedic Clinic, Inc. | Danville | Virginia | 24541 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 108 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01972568, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 2, 2018 · Synced Nov 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01972568 live on ClinicalTrials.gov.